Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7312)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2017 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Micheu MM, Dorobantu M. Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction. World J Stem Cells 2017; 9(4): 68-76 [PMID: 28491241 DOI: 10.4252/wjsc.v9.i4.68] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v9/i4/68.htm |
| Number | Citing Articles |
| 1 |
Orie Saino, Yuko Ogawa, Kazuta Yasui, Akihiro Fuchizaki, Rie Akamatsu, Yoriko Irie, Mitsunobu Tanaka, Takafumi Kimura, Akihiko Taguchi. Integrin β2 Plays a Significant Role in Therapeutic Angiogenesis Through Hematopoietic Stem Cell Transplantation. Life 2025; 15(2): 195 doi: 10.3390/life15020195
|
| 2 |
Martina Colicchia, Daniel A. Jones, Anne-Marie Beirne, Mohsin Hussain, Deshan Weeraman, Krishnaraj Rathod, Jessry Veerapen, Mark Lowdell, Anthony Mathur. Umbilical cord–derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data. Cytotherapy 2019; 21(10): 1007 doi: 10.1016/j.jcyt.2019.04.056
|
| 3 |
Maria Dorobantu, Nicoleta-Monica Popa-Fotea, Mihaela Popa, Iulia Rusu, Miruna Mihaela Micheu. Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. World Journal of Stem Cells 2017; 9(12): 203-218 doi: 10.4252/wjsc.v9.i12.203
|
| 4 |
Yuka Okinaka, Akie Kikuchi-Taura, Yukiko Takeuchi, Yuko Ogawa, Johannes Boltze, Sheraz Gul, Carsten Claussen, Akihiko Taguchi. Clot-Derived Contaminants in Transplanted Bone Marrow Mononuclear Cells Impair the Therapeutic Effect in Stroke. Stroke 2019; 50(10): 2883 doi: 10.1161/STROKEAHA.119.026669
|
| 5 |
Gabriela Maciel Lopes, Patrícia Bencke Grudzinski, Nance Beyer Nardi, Natalia Motta Leguisamo. Cell Therapy Improves Cardiac Function in Anthracycline-Induced Cardiomyopathy Preclinical Models: A Systematic Review and Meta-Analysis. Stem Cells and Development 2020; 29(19): 1247 doi: 10.1089/scd.2020.0044
|
| 6 |
Anthony Mathur, Doo Sun Sim, Fizzah Choudry, Jessry Veerapen, Martina Colicchia, Tymoteusz Turlejski, Mohsin Hussain, Stephen Hamshere, Didier Locca, Roby Rakhit, Tom Crake, Jens Kastrup, Samir Agrawal, Daniel A. Jones, John Martin. Five‐year follow‐up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE‐AMI trial. ESC Heart Failure 2022; 9(2): 1152 doi: 10.1002/ehf2.13786
|
| 7 |
Stephen E. Epstein, Michael J. Lipinski, Dror Luger. Persistent Inflammation, Stem Cell–Induced Systemic Anti‐Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure. Journal of the American Heart Association 2018; 7(4) doi: 10.1161/JAHA.118.008524
|
| 8 |
Alireza Hosseinpour, Fatemeh Kheshti, Asma Kazemi, Armin Attar. Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular function: a meta-analysis of clinical trials. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02883-3
|
| 9 |
Miruna Mihaela Micheu, Alina Ioana Scarlatescu, Alexandru Scafa-Udriste, Maria Dorobantu. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the Spotlight. Cells 2018; 7(12): 255 doi: 10.3390/cells7120255
|
| 10 |
Mariah Madigan, Rony Atoui. Therapeutic Use of Stem Cells for Myocardial Infarction. Bioengineering 2018; 5(2): 28 doi: 10.3390/bioengineering5020028
|
| 11 |
Syed Ahsan Ali, Zahra Mahmood, Zulkiffil Mubarak, Manahil Asad, Muhammad Taha Sarfraz Chaudhri, Lamiah Bilal, Tehniat Ashraf, Tarek N Khalifa, Thasneem Ashraf, Falaknaz Saleem, Fathima Masharifa Ahamed, Shoaib Tarar. Assessing the Potential Benefits of Stem Cell Therapy in Cardiac Regeneration for Patients With Ischemic Heart Disease. Cureus 2025; doi: 10.7759/cureus.76770
|
| 12 |
Philippe Menasché. Cardiac cell therapy: Current status, challenges and perspectives. Archives of Cardiovascular Diseases 2020; 113(4): 285 doi: 10.1016/j.acvd.2020.01.002
|
| 13 |
Miruna Mihaela Micheu. Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?. World Journal of Stem Cells 2019; 11(8): 445-451 doi: 10.4252/wjsc.v11.i8.445
|